Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive disease, with patients diagnosed with either early-stage, limited stage, or extensive stage of SCLC tumor progression. Discovering and targeting the functional biomarkers for SCLC will be crucial in understanding the molecular basis underlying SCLC tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboyama, Natsumi, Wang, Ru, Szczepanski, Aileen Patricia, Chen, Huanhuan, Zhao, Zibo, Shi, Lei, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993689/
https://www.ncbi.nlm.nih.gov/pubmed/35194152
http://dx.doi.org/10.1038/s41388-022-02240-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993689/
https://www.ncbi.nlm.nih.gov/pubmed/35194152
http://dx.doi.org/10.1038/s41388-022-02240-x

Ejemplares similares